Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users

Biological Psychiatry

Volumn 72, Issue 10, 2012, Pages 811-816

  Di Forti, Marta ^a   Iyegbe, Conrad ^a   Sallis, Hannah ^a   Kolliakou, Anna ^a   Falcone, M Aurora ^a   Paparelli, Alessandra ^a   Sirianni, Miriam ^b   La Cascia, Caterina ^c   Stilo, Simona A ^a   Marques, Tiago Reis ^a   Handley, Rowena ^a   Mondelli, Valeria ^a   Dazzan, Paola ^a   Pariante, Carmine ^a   David, Anthony S ^a   Morgan, Craig ^a   Powell, John ^a   Murray, Robin M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Catanzaro Medical School   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

AKT1 gene; cannabis use; gene environment interaction; psychosis; schizophrenia; signaling pathways

Indexed keywords

CANNABIS;

ADULT; AGED; AKT1 GENE; ARTICLE; CANNABIS ADDICTION; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEMOGRAPHY; EPISODE OF CARE; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LONDON; MALE; MARIJUANA ABUSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84867743306     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.06.020     Document Type: Article

References (40)

1. United Nations Office on Drugs and Crime UNODC World Drug Report 2009 2009
2. C. Henquet, R. Murray, D. Linszen, J. van Os The environment and schizophrenia: The role of cannabis use Schizophr Bull 31 2005 608 612
3. T.H. Moore, S. Zammit, A. Lingford-Hughes, T.R. Barnes, P.B. Jones, M. Burke, G. Lewis Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review Lancet 370 2007 319 328
4. A. Caspi, T.E. Moffitt, M. Cannon, J. McClay, R. Murray, H. Harrington Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene x environment interaction Biol Psychiatry 57 2005 1117 1127
5. C. Henquet, A. Rosa, L. Krabbendam, S. Papiol, L. Fananas, M. Drukker An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition Neuropsychopharmacology 31 2006 2748 2757
6. D.L. Thiselton, V.I. Vladimirov, P.H. Kuo, J. McClay, B. Wormley, A. Fanous AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families Biol Psychiatry 63 2008 449 457
7. F. Karege, A. Meary, N. Perroud, S. Jamain, M. Leboyer, E. Ballmann Genetic overlap between schizophrenia and bipolar disorder: A study with AKT1 gene variants and clinical phenotypes Schizophr Res 135 2012 8 14
8. Z. Bolog, I. Kiss, K.M. Bolcs New schizophrenia loci may converge on the same cellular mechanism: The AKT pathway Am J Psychiatry 169 2012 3
9. Y. Bozzi, M. Dunleavy, D.C. Henshall Cell signaling underlying epileptic behavior Front Behav Neurosci 5 2011 45
10. A. Ozaita, E. Puighermanal, R. Maldonado Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain J Neurochem 102 2007 1105 1114
11. T. Gomez del Pulgar, G. Velasco, M. Guzman The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt Biochem J 347 2000 369 373
12. R. van Winkel Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: Sibling analysis and proband follow-up Arch Gen Psychiatry 68 2011 148 157
13. R. van Winkel, N.J. van Beveren, C. Simons Genetic Risk and Outcome of Psychosis (GROUP) Investigators AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder Neuropsychopharmacology 36 2011 2529 2537
14. S. Bhattacharyya, Z. Atakan, R. Martin-Santos, J.A. Crippa, J. Kambeitz, D. Prata et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of d-9-tetrahydrocannabinol on midbrain and striatal function [published online ahead of print January 31] Mol Psychiatry 2012
15. L.E. Duncan, M.C. Keller A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry Am J Psychiatry 168 2011 1041 1049
16. World Health Organization International Classification of Diseases, 10th Edition (ICD-10): Classification of Mental and Behavioural Disorders 1992 World Health Organization Geneva
17. World Health Organization Schedules for Clinical Assessment in Neuropsychiatry (SCAN) 1992 World Health Organization Geneva
18. Office for National Statistics 2011 Census www.statistics.gov.uk/census 2011
19. P. Bebbington, T. Nayani The Psychosis Screening Questionnaire Int J Methods Psychiatr Res 5 1995 11 19
20. R. Mallett, J. Leff, D. Bhugra, D. Pang, J.H. Zhao Social environment, ethnicity and schizophrenia A case-control study Soc Psychiatry Psychiatr Epidemiol 37 2002 329 335
21. M. Di Forti, C. Morgan, P. Dazzan, C. Pariante, V. Mondelli, T.R. Marques High-potency cannabis and the risk of psychosis Br J Psychiatry 195 2009 488 491
22. D. Falush, M. Stephens, J.K. Pritchard Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies Genetics 164 2003 1567 1587
23. P.D. Morrison, R.M. Murray From real-world events to psychosis: The emerging neuropharmacology of delusions Schizophr Bull 35 2009 668 674
24. L. Adermark, G. Talani, D.M. Lovinger Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity Eur J Neurosci 29 2009 32 41
25. M. Laruelle, A. Abi-Dargham Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies J Psychopharmacol 13 1999 358 371
26. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L.S. Kegeles Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci U S A 97 2000 8104 8109
27. S. Zammit, G. Spurlock, H. Williams, N. Norton, N. Williams, M.C. O'Donovan, M.J. Owen Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: Interactions with tobacco and cannabis use Br J Psychiatry 191 2007 402 407
28. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
29. M.P. Scheid, J.R. Woodgett PKB/AKT: Functional insights from genetic models Nat Rev Mol Cell Biol 2 2011 760 768
30. G. Blasi, F. Napolitano, G. Ursinia, P. Taurisano, R. Romanoa, G. Caforio DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia Proc Natl Acad Sci U S A 108 2011 1158 1163
31. M.G. Sanchez, L. Ruiz-Llorente, A.M. Sanchez, I. Diaz-Laviada Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells Involvement in Raf-1 stimulation and NGF induction Cell Signal 15 2003 851 859
32. J.M. Beaulieu, R.R. Gainetdinov, M.G. Caron The Akt-GSK-3 signaling cascade in the actions of dopamine Trends Pharmacol Sci 28 2007 166 172
33. J.M. Beaulieu, E. Tirotta, T.D. Sotnikova, B. Masri, A. Salahpour, R.R. Gainetdinov Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo J Neurosci 27 2007 881 885
34. British Crime Survey Crime Surveys Programme Research Development and Statistics Crime Reduction and Community Safety Group Home Office 2007/2008
35. National Center for Biotechnology Information dbSNP Short Genetic Variations www.ncbi.nlm.nih.gov/projects/SNP 2012 Accessed February 2012
36. D.M. Altshuler, R.A. Gibbs, L. Peltonen, D.M. Altshuler, R.A. Gibbs The International HapMap 3 Consortium Integrating common and rare genetic variation in diverse human populations Nature 467 2012 52 58
37. H.-Y. Tan, K.K. Nicodemus, Q. Chen, Z. Li, J.K. Brooke, R. Honea Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans J Clin Invest 118 2008 2200 2208
38. M.J. Khoury, W.D. Flanders Non traditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls! Am J Epidemiol 144 1996 207 213
39. T.E. Moffitt, A. Caspi, M. Rutter Strategy for investigating interactions between measured genes and measured environments Arch Gen Psychiatry 62 2005 473 481
40. S.M. Purcell, N.R. Wray, J.L. Stone, P.M. Visscher, M.C. O'Donovan International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752